ReviewRSC advances2025
New synthetic approaches for the construction of 2-aminophenoxazinone architectures.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Aerobic oxidative condensation for the synthesis of phenoxazinone and phenazine derivatives catalyzed by an iron-porphyrin complex with a pendant imidazole ligand.RSC advances · 2026Article
- Optimization of sporulation of Trametes sanguinea ZHSJ and untargeted metabolomics of spores, mycelium and fruiting body.Scientific reports · 2026Article
- A coordinative partnership in tungsten chemistry: N-bound isothiocyanate and a tridentate pyrazolone-Schiff base in a hexacoordinate [WOJournal of computer-aided molecular design · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elaborated molecular architectures, specifically those containing a 2-aminophenoxazinone scaffold, belong to one of the most ubiquitous and prominent classes of heterocyclic frameworks, going from natural products to biologically active pharmaceutical molecules and from agrochemicals to functional materials and polymers. Therefore, efficient synthetic strategies for the assembly of 2-aminophenoxazinone frameworks are always in demand and have gained attention in academic and industrial communities. Methodologies that involve cascade reactions generally catalyzed by transition metal complexes, such as iron, cobalt, manganese, copper, and zinc complexes, have stood out as a representative approach. Over the past few decades, a great deal of versatile, atom-economic, and straightforward protocols have been reported for the generation of value-added 2-aminophenoxazinone frameworks in a sustainable, powerful, and applicable manner. The state-of-the-art methodologies toward the construction of 2-aminophenoxazinone skeletons are summarized in this review, which could be divided into four categories: (1) construction of 2-aminophenoxazinone compounds catalyzed by transition metal complexes; (2) construction of 2-aminophenoxazinone compounds catalyzed by biosynthetic enzymes; (3) synthetic process routes of 2-aminophenoxazinone compounds; and (4) construction of 2-aminophenoxazinone compounds
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.